US 12385012
Methods and compositions for inducing hematopoietic cell differentiation
granted A61PA61P37/02
Quick answer
US patent 12385012 (Methods and compositions for inducing hematopoietic cell differentiation) held by Fate Therapeutics, Inc. expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P37/02